Modified-FOLFIRINOX Beneficial in Resected Pancreatic Cancer
WEDNESDAY, Dec. 19, 2018 -- For patients with resected pancreatic cancer, adjuvant therapy with a modified regimen of chemotherapy with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX), compared with gemcitabine, results in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Pancreas | Pancreatic Cancer | Pharmaceuticals